These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24875904)

  • 1. RANKL expression in myeloma cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNFα in the microenvironment.
    Yuan L; Chan GC; Fung KL; Chim CS
    Biochim Biophys Acta; 2014 Sep; 1843(9):1834-8. PubMed ID: 24875904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
    Pitari MR; Rossi M; Amodio N; Botta C; Morelli E; Federico C; Gullà A; Caracciolo D; Di Martino MT; Arbitrio M; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2015 Sep; 6(29):27343-58. PubMed ID: 26160841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules.
    Bolzoni M; Storti P; Bonomini S; Todoerti K; Guasco D; Toscani D; Agnelli L; Neri A; Rizzoli V; Giuliani N
    Exp Hematol; 2013 Apr; 41(4):387-97.e1. PubMed ID: 23178378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.
    Ji W; Yang L; Yuan J; Yang L; Zhang M; Qi D; Duan X; Xuan A; Zhang W; Lu J; Zhuang Z; Zeng G
    Carcinogenesis; 2013 Feb; 34(2):446-53. PubMed ID: 23125218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chim CS
    J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
    Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
    Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
    Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
    Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
    Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
    Berenstein R; Blau O; Nogai A; Waechter M; Slonova E; Schmidt-Hieber M; Kunitz A; Pezzutto A; Doerken B; Blau IW
    BMC Cancer; 2015 Feb; 15():68. PubMed ID: 25886144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
    Wang H; Wu J; Meng X; Ying X; Zuo Y; Liu R; Pan Z; Kang T; Huang W
    Carcinogenesis; 2011 Jul; 32(7):1033-42. PubMed ID: 21565830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
    Zdzisińska B; Bojarska-Junak A; Walter-Croneck A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):153-63. PubMed ID: 20157786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of MicroRNA-148/152 Family in the Hematological Malignancies].
    Wang XX; Wang Y; Wang PP; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1173-8. PubMed ID: 26314468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of bta-miR-29b promoter regions DNA methylation in regulating miR-29b expression and bovine viral diarrhea virus NADL replication in MDBK cells.
    Fu Q; Shi H; Chen C
    Arch Virol; 2017 Feb; 162(2):401-408. PubMed ID: 27766427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
    Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
    Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.